Advertisement
Singapore markets closed

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,009.22
    -62.41 (-1.23%)
     

  • Dow

    37,825.19
    -635.73 (-1.65%)
     

  • Nasdaq

    15,481.91
    -230.83 (-1.47%)
     

  • Bitcoin USD

    63,641.85
    -1,801.89 (-2.75%)
     

  • CMC Crypto 200

    1,378.13
    -4.45 (-0.32%)
     

  • FTSE 100

    8,054.77
    +14.39 (+0.18%)
     

  • Gold

    2,336.30
    -2.10 (-0.09%)
     

  • Crude Oil

    82.04
    -0.77 (-0.93%)
     

  • 10-Yr Bond

    4.7160
    +0.0640 (+1.38%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Endologix: 4Q Earnings Snapshot

Associated Press
Updated ·1-min read

IRVINE, Calif. (AP) _ Endologix Inc. (ELGX) on Wednesday reported a loss of $7.8 million in its fourth quarter.

The Irvine, California-based company said it had a loss of 40 cents per share. Losses, adjusted for non-recurring gains, were 42 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 70 cents per share.

The medical device company posted revenue of $35.8 million in the period.

For the year, the company reported that its loss narrowed to $64.8 million, or $3.84 per share. Revenue was reported as $143.4 million.

ADVERTISEMENT

Endologix expects full-year revenue of $145 million.

In the final minutes of trading on Wednesday, the company's shares hit 89 cents. A year ago, they were trading at $5.46.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ELGX at https://www.zacks.com/ap/ELGX